Literature DB >> 27860482

Long Noncoding RNA EWSAT1 Promotes Osteosarcoma Cell Growth and Metastasis Through Suppression of MEG3 Expression.

Lishan Sun1, Cheng Yang1, Juan Xu2, Yanhong Feng3, Liguo Wang1, Tao Cui1.   

Abstract

Osteosarcoma (OS) is the most common primary bone tumor in children and adolescents. Long noncoding RNAs (lncRNAs) are a class of transcriptional products of the genome without protein-coding potential. Recently, lncRNA Ewing sarcoma-associated transcript 1 (EWSAT1) was functionally identified in Ewing sarcoma, a highly aggressive primary pediatric bone tumor. However, whether EWSAT1 plays a role in OS remains unclear. In the present study, gain- and loss-of-function assays demonstrated that EWSAT1 enhanced OS cell proliferation, migration, and invasion. Further mechanistic studies found that EWSAT1 positively regulated lncRNA MEG3 expression in the transcriptional level. Finally, we observed that EWSAT1 facilitates OS cell growth and metastasis through regulation of MEG3, suggesting that EWSAT1-MEG3 axis might be a promising target for OS treatment.

Entities:  

Keywords:  EWSAT1; MEG3; lncRNA; metastasis

Mesh:

Substances:

Year:  2016        PMID: 27860482     DOI: 10.1089/dna.2016.3467

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  15 in total

Review 1.  Emerging roles of non-coding RNAs in the pathogenesis, diagnosis and prognosis of osteosarcoma.

Authors:  Chongchong Wang; Juehua Jing; Li Cheng
Journal:  Invest New Drugs       Date:  2018-08-06       Impact factor: 3.850

2.  LncRNA ODRUL Contributes to Osteosarcoma Progression through the miR-3182/MMP2 Axis.

Authors:  Kun-Peng Zhu; Xiao-Long Ma; Chun-Lin Zhang
Journal:  Mol Ther       Date:  2017-07-05       Impact factor: 11.454

3.  Long noncoding RNA DLX6-AS1 targets miR-124-3p/CDK4 to accelerate Ewing's sarcoma.

Authors:  Xiaomei Lei; Siping Yang; Yuanyuan Yang; Juan Zhang; Yue Wang; Minhui Cao
Journal:  Am J Transl Res       Date:  2019-10-15       Impact factor: 4.060

Review 4.  Epigenetic and Transcriptomic Regulation Landscape in HPV+ Cancers: Biological and Clinical Implications.

Authors:  Rosario Castro-Oropeza; Patricia Piña-Sánchez
Journal:  Front Genet       Date:  2022-06-14       Impact factor: 4.772

Review 5.  Zooming in on Long Non-Coding RNAs in Ewing Sarcoma Pathogenesis.

Authors:  Dave N T Aryee; Valerie Fock; Utkarsh Kapoor; Branka Radic-Sarikas; Heinrich Kovar
Journal:  Cells       Date:  2022-04-08       Impact factor: 7.666

6.  LncRNA EWSAT1 promotes ovarian cancer progression through targeting miR-330-5p expression.

Authors:  Xin Fu; Li Zhang; Li Dan; Ke Wang; Yue Xu
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

7.  Long non-coding RNA ZFAS1 sponges miR-486 to promote osteosarcoma cells progression and metastasis in vitro and vivo.

Authors:  Nan Li; Zhen-Hui Sun; Min Fang; Jing-Yi Xin; Chun-You Wan
Journal:  Oncotarget       Date:  2017-10-24

8.  Hypermethylation of MEG3 promoter correlates with inactivation of MEG3 and poor prognosis in patients with retinoblastoma.

Authors:  Yali Gao; Peng Huang; Jun Zhang
Journal:  J Transl Med       Date:  2017-12-29       Impact factor: 5.531

Review 9.  Potentials of Long Noncoding RNAs (LncRNAs) in Sarcoma: From Biomarkers to Therapeutic Targets.

Authors:  Li Min; Cassandra Garbutt; Chongqi Tu; Francis Hornicek; Zhenfeng Duan
Journal:  Int J Mol Sci       Date:  2017-03-29       Impact factor: 5.923

10.  Long noncoding RNA MEG3, a potential novel biomarker to predict the clinical outcome of cancer patients: a meta-analysis.

Authors:  Xiangrong Cui; Xuan Jing; Chunlan Long; Jie Tian; Jing Zhu
Journal:  Oncotarget       Date:  2017-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.